Company
Voronoi, Inc
Voronoi, Inc has 1 drug tracked on RxWires: 1 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| VRN101099 | Phase 1 | HER2-positive Solid Tumors |
Latest
No recent events.
Follow Voronoi, Inc on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.